Novartis

Articles
Glass Medicine Vials and botox, hualuronic, collagen or flu Syringe on a white background.

US physicians favour biosimilars

As the US FDA moves towards issuing final guidelines on biosimilars, recent research with specialists in five main therapy areas suggests they are willing to embrace them if efficacy and safety

News
Novartis-AU-HQ

New dermatology licence for Xolair

Xolair has gained EU approval as the first ever add-on therapy to treat chronic spontaneous urticaria (CSU) in adult and adolescent patients with inadequate response to H1-antihistamine tre

Articles
Novartis-AU-HQ

A history of Novartis

Novartis is one of the world's top pharmaceutical companies, and along with neighbours Roche, the mainstay of Switzerland's centuries-long contribution to new medicines.